ALLO
Price
$2.92
Change
+$0.16 (+5.80%)
Updated
May 1, 6:59 PM EST
97 days until earnings call
DNLI
Price
$16.16
Change
+$0.72 (+4.66%)
Updated
May 1, 6:59 PM EST
Earnings call today
Ad is loading...

ALLO vs DNLI ᐉ Comparison: Which is Better to Invest?

Header iconALLO vs DNLI Comparison
Open Charts ALLO vs DNLIBanner chart's image
Allogene Therapeutics
Price$2.92
Change+$0.16 (+5.80%)
Volume$1.6M
CapitalizationN/A
Denali Therapeutics
Price$16.16
Change+$0.72 (+4.66%)
Volume$818.87K
CapitalizationN/A
View a ticker or compare two or three
ALLO vs DNLI Comparison Chart

Loading...

ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ALLO vs. DNLI commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Sell and DNLI is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (ALLO: $2.91 vs. DNLI: $16.15)
Brand notoriety: ALLO and DNLI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 93% vs. DNLI: 79%
Market capitalization -- ALLO: $497.66M vs. DNLI: $2.3B
ALLO [@Biotechnology] is valued at $497.66M. DNLI’s [@Biotechnology] market capitalization is $2.3B. The market cap for tickers in the [@Biotechnology] industry ranges from $578.54B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileDNLI’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • DNLI’s FA Score: 0 green, 5 red.
According to our system of comparison, both ALLO and DNLI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 3 TA indicator(s) are bullish while DNLI’s TA Score has 4 bullish TA indicator(s).

  • ALLO’s TA Score: 3 bullish, 4 bearish.
  • DNLI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both ALLO and DNLI are a bad buy in the short-term.

Price Growth

ALLO (@Biotechnology) experienced а -4.11% price change this week, while DNLI (@Biotechnology) price change was +3.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.39%. For the same industry, the average monthly price growth was -4.43%, and the average quarterly price growth was +1237.50%.

Reported Earning Dates

ALLO is expected to report earnings on Aug 07, 2024.

DNLI is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (+3.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ALLO with price predictions.
OPEN
A.I.dvisor published
a Summary for DNLI with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
DNLI($2.3B) has a higher market cap than ALLO($498M). ALLO YTD gains are higher at: -9.190 vs. DNLI (-24.744).
ALLODNLIALLO / DNLI
Capitalization498M2.3B22%
EBITDAN/AN/A-
Gain YTD-9.190-24.74437%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
DNLI: Fundamental Ratings
DNLI
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
82
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
90
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLODNLI
RSI
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
87%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Ad is loading...
ALLODaily Signal changed days agoGain/Loss if shorted
 
Show more...
DNLIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NEWCX73.88N/A
N/A
American Funds New World C
GLNBX19.10N/A
N/A
MFS Global New Discovery B
HFDYX18.86N/A
N/A
Hartford Schroders US MidCap Opps Y
COSVX10.64-0.03
-0.28%
Columbia Overseas Value Adv
IPFPX51.99-0.18
-0.35%
Poplar Forest Partners Institutional

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with NTLA. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+5.62%
NTLA - ALLO
61%
Loosely correlated
+5.14%
BEAM - ALLO
55%
Loosely correlated
+2.45%
DNLI - ALLO
51%
Loosely correlated
+4.60%
ATAI - ALLO
48%
Loosely correlated
+3.54%
EDIT - ALLO
48%
Loosely correlated
+4.70%
More